Cardio Diagnostics Holdings is trading 5.10% up at $2.06, with no clear company-specific announcement explaining the October 5 move. - The latest reported filing was a Form 4 dated October 2. - The S&P 500 and Nasdaq were higher, potentially providing a supportive backdrop; available evidence does not establish that this caused the stock’s gain.